genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Latest
All
More
Cancer
Force of Nature: Caribou Biosciences Hits Clinical Runway with CRISPR-based Cancer Therapeutics
GEN Edge
Derisking Genetic Medicines with NeuBase and Ring Therapeutics
Drug Discovery
Door Busters: Entrada Therapeutics Is Engaging Inaccessible Intracellular Targets
Artificial Intelligence
StockWatch: Nvidia Rides AI Wave to 180% Stock Surge
GEN Edge
Life Sciences M&A: Drivers and Market Outlook
Artificial Intelligence
Spin Me Round: iBio Reemerges as Innovator of Precision Antibody Immunotherapies
Artificial Intelligence
No-nonsense: Alltrna Touts tRNA Therapeutics to Treat Thousands of Diseases
GEN Edge
ASGCT News: Metagenomi’s Gene-Editing Palette Enables Plug-and-play Pipeline
StockWatch: FTC vs. Amgen-Horizon Could Slam Brakes on Biotech M&A
Cancer
ASGCT News: Kelonia Lentiviral Particles May Solve In Vivo Delivery Hurdles for CAR T Cells
Cancer
ASGCT News: Siren Biotechnology Hails Universal Gene Therapy for Oncology
Absci Eyes IND for Platform’s First de novo Antibody within Two Years
StockWatch: Catalent Cuts Revenue, EBITDA Forecasts, Rattling Investors
Taysha Faces Stock Delisting, Scraps $75M Durham Manufacturing Facility
StockWatch: Illumina Stays Mum as Short Seller Targets Icahn
GEN Edge
Twist and Shout: Helix is Weaving Population Genomics into the Healthcare Fabric
StockWatch: Illumina Wins Back Two Analysts on Q1 Results
Artificial Intelligence
Big Pharma Leadership Decries the Inflation Reduction Act
Project Vitality: Pfizer Pursues Vaccine R&D Expansion
Close to the Edge
BIO CEO Rachel King Outlines Industry’s Challenges on “Close to the Edge”
Close to the Edge
Carl Icahn States His Case for Change at Illumina on “Close to the Edge”
Cancer
The Immaculate Conception of Gleevec, As Told by Brian Druker
Drug Discovery
FDA Commissioner Attributes U.S. Healthcare Shortcomings to Misinformation and Wealth Disparity
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1
Drug Discovery
Licit Activity: MindMed Collaborators Announce Positive Phase II Results for LSD in Major Depressive Disorder
StockWatch: Illumina Shares Steady as Icahn Escalates Proxy Fight
Drug Discovery
Go Higher: Atai Life Sciences Is Moving the Dial on Psychedelic Medicine Clinical Trial Outcomes
BioNTech, DualityBio Ink Up-to-$1.7B Cancer ADC Collaboration
StockWatch: COPD Data, Analysts, Treg Cell Therapy Deal Lift Regeneron
GEN Edge
Diagnosing Vicariously: Karius Uses AI to Advance Infectious Disease Diagnostics
Load more
Scroll Up
